Literature DB >> 8180130

The biological effects of antisense N-myc expression in human neuroblastoma.

M L Schmidt1, H R Salwen, C F Manohar, N Ikegaki, S L Cohn.   

Abstract

Although N-myc amplification and overexpression are believed to play an important role in determining the clinical behavior of neuroblastoma (NB), the exact function of N-myc in NB cell growth and differentiation remains unknown. To better understand the function of N-myc, an established human NB cell line was transfected with N-myc antisense (AS) complementary DNA in an effort to down-regulate N-myc gene expression. Five clones expressing AS N-myc RNA have been maintained in culture for over 2 years. Compared to control cells, a 30-69% decrease in the quantity of N-myc protein was demonstrated by Western blot analysis in 4 of the 5 AS clones. All 5 of the AS clones exhibited a 50-75% decrease in colony formation in soft agar assays compared to control cells. In addition, all 5 AS clones expressed a 3.2-kilobase protein kinase C-alpha transcript, whereas this message was not detected by Northern blot analysis in any of the control clones. These results suggest that N-myc may play an important role in NB cell growth and that antisense N-myc expression is associated with an induction of protein kinase C-alpha RNA expression. Further characterization of the AS clones may provide insight into the function of N-myc and may thus lead to a better understanding of the role that N-myc plays in determining the clinical behavior of this childhood neoplasm.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180130

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

1.  N-Myc differentially regulates expression of MXI1 isoforms in neuroblastoma.

Authors:  Michael B Armstrong; Rajen J Mody; D Christian Ellis; Adam B Hill; David A Erichsen; Daniel S Wechsler
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3.

Authors:  L R Santiago; L C Erickson; I Hanin
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

3.  Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

Authors:  Louis Chesler; Chris Schlieve; David D Goldenberg; Anna Kenney; Grace Kim; Alex McMillan; Katherine K Matthay; David Rowitch; William A Weiss
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

4.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.

Authors:  J Q Cheng; B Ruggeri; W M Klein; G Sonoda; D A Altomare; D K Watson; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

5.  Modulation of N-myc expression alters the invasiveness of neuroblastoma.

Authors:  L A Goodman; B C Liu; C J Thiele; M L Schmidt; S L Cohn; J M Yamashiro; D S Pai; N Ikegaki; R K Wada
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

6.  Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

Authors:  Qiwei Yang; Yufeng Tian; Kelly R Ostler; Alexandre Chlenski; Lisa J Guerrero; Helen R Salwen; Lucy A Godley; Susan L Cohn
Journal:  BMC Cancer       Date:  2010-06-14       Impact factor: 4.430

7.  Mechanisms of embryonal tumor initiation: distinct roles for MycN expression and MYCN amplification.

Authors:  Loen M Hansford; Wayne D Thomas; Joanna M Keating; Catherine A Burkhart; Anne E Peaston; Murray D Norris; Michelle Haber; Patricia J Armati; William A Weiss; Glenn M Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

8.  Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.

Authors:  Song Gu; Yufeng Tian; Alexandre Chlenski; Helen R Salwen; Ziyan Lu; J Usha Raj; Qiwei Yang
Journal:  Anticancer Drugs       Date:  2012-11       Impact factor: 2.248

Review 9.  MYCN, neuroblastoma and focal adhesion kinase (FAK).

Authors:  Elizabeth A Beierle
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

10.  MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.

Authors:  Diana T Lau; Claudia L Flemming; Samuele Gherardi; Giovanni Perini; André Oberthuer; Matthias Fischer; Dilafruz Juraeva; Benedikt Brors; Chengyuan Xue; Murray D Norris; Glenn M Marshall; Michelle Haber; Jamie I Fletcher; Lesley J Ashton
Journal:  Oncotarget       Date:  2015-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.